Laurus is a leading research and development driven pharmaceutical company in India. The Company has grown consistently to become one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs) for anti-retroviral (ARV) and Hepatitis C. Laurus also manufactures APIs in Oncology and other therapeutic areas. Its strategic and early investments in R&D and manufacturing infrastructure have enabled it to become one of the leading suppliers of APIs in the ARV therapeutic area. Initiatives are in place to develop a Finished Dosage Forms capabilities on the back of existing strengths in APIs. The Company is also driving growth opportunities in the Synthesis and Ingredients businesses.

 

Company:

   Laurus Labs Limited
 

Headquarters Address:

 2nd Floor Serene Towers, Rd No 5, Banjarahills,
Hyderabad 500034
India
 

Main Telephone:

 +91 40 3980 4333
 

Website:

www.lauruslabs.com

 

Ticker/ISIN:

 540222(MUMBAI)/INE947Q01010

LAURUSLABS(NSI)/INE947Q01010

 

Type of Organization:

 Public
 

Industry:

 Pharmaceutical
 

Earnings Release Dates:

4th Quarter: May 18, 2017

 

Key Executives:

CEO: Satyanarayana Chava

CFO: V V Ravi Kumar

 

Public Relations

Contact:

 Pavan Kumar

Phone:

 +91 40 3980 4380

Email:

pavankumar.n@lauruslabs.com